What is the ticker symbol for Achilles Therapeutics?

Achilles Therapeutics trades under the ticker ACHL on NASDAQ.

What sector does Achilles Therapeutics operate in?

Achilles Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ACHL in a portfolio?

PortView shows ACHL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Achilles Therapeutics (ACHL) Stock Analysis

NASDAQHealthcareBiotechnology

$1.48+0.68%

1-year price historyRange $0.70 – $1.49

52-week range$1.48

$0.63$1.51

What Achilles Therapeutics does

Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.

Key metrics

Market cap

$60.83M

P/E (TTM)

-0.89

EPS (TTM)

$-1.66

Beta

1.25

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.33

200-day avg

$1.03

52-week high

$1.51

52-week low

$0.63

CEO

Iraj Ali

ETFs linked to ACHL

Broad-market and Healthcare sector ETFs an investor holding Achilles Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ACHL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ACHL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Achilles Therapeutics?: Achilles Therapeutics trades under the ticker ACHL on NASDAQ.
Which exchange is ACHL listed on?: ACHL is listed on NASDAQ.
What sector does Achilles Therapeutics operate in?: Achilles Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ACHL in a portfolio?: PortView shows ACHL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.